Zika Rapid Test Device (WB/S/P)

The Zika Rapid Test Device is a rapid screening aid used to detect Zika virus infection markers in whole blood, serum, or plasma samples. Zika virus is mainly transmitted through infected Aedes mosquitoes and may require laboratory confirmation such as RT-PCR or IgM antibody testing.

• Many Zika infections are mild or may not show symptoms.
• When symptoms occur, they can resemble dengue, chikungunya, or other viral infections.
• Zika testing may support travel-related fever evaluation, mosquito-borne disease surveillance, and public health outbreak response.
• Pregnancy-related Zika risk should always be evaluated under medical guidance.

The Zika Rapid Test Device by LARKSOIS Pharma may be used in professional infectious disease and mosquito-borne disease screening environments.

Applications

• Infectious disease screening
• Travel-related fever evaluation
• Mosquito-borne disease surveillance
• Pregnancy-risk evaluation under medical guidance
• Public health outbreak response
• Differential testing with dengue and chikungunya
• Hospital and laboratory diagnostic workflows
• Professional point-of-care testing
• International diagnostic distribution

• The Zika Rapid Test Device generally works through a lateral flow immunoassay method.
• A whole blood, serum, or plasma sample is added to the test device.
• If the target Zika marker is present, it reacts with specific test components on the membrane.
• A visible result line appears according to the product insert.
• A control line confirms correct sample flow and proper test performance.

The Zika Rapid Test Device uses rapid lateral flow immunochromatographic technology for professional screening of Zika virus infection markers in whole blood, serum, or plasma specimens.

Benefits

• Rapid Zika screening support
• Suitable for whole blood, serum, or plasma
• Simple lateral flow test format
• Professional diagnostic application
• Useful in infectious disease screening programs
• Supports point-of-care testing workflows
• Practical for hospitals, clinics, and laboratories
• Designed for international healthcare markets

The Zika Rapid Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable rapid test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample area
• Add buffer if required according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Zika Rapid Test Device by LARKSOIS Pharma is designed for detection of Zika virus infection markers in whole blood, serum, or plasma specimens. Detection may support professional screening and further laboratory confirmation when required.

• The Zika Rapid Test Device may support screening of suspected Zika virus infection.
• The test may be useful in travel health centers and mosquito-borne disease surveillance programs.
• Zika screening may support differential evaluation where dengue or chikungunya-like symptoms are present.
• Positive or suspicious results may require RT-PCR, IgM antibody testing, or additional laboratory confirmation.
• Results should be interpreted with symptoms, exposure history, pregnancy status when relevant, and clinical evaluation.

The Zika Rapid Test Device is a screening aid and not a standalone final diagnosis. Zika test interpretation can be complex because symptoms may overlap with dengue and chikungunya, and antibody cross-reactivity may occur.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• Cross-reactivity with related flaviviruses may occur
• Confirmatory laboratory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Rapid Zika screening support
• Suitable for whole blood, serum, or plasma
• Simple lateral flow test format
• Professional diagnostic application
• Useful in infectious disease screening programs
• Supports point-of-care testing workflows
• Practical for hospitals, clinics, and laboratories
• Quality-focused rapid test solution from LARKSOIS Pharma

Note

The Zika Rapid Test Device by LARKSOIS Pharma is designed for professional healthcare markets and international diagnostic supply.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test device on a clean and flat surface
• Add whole blood, serum, or plasma to the sample area
• Add buffer if required according to the product insert
• Wait for the recommended reaction time
• Read the test and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

A positive result means Zika virus infection marker may be present in the specimen. The result should be interpreted with symptoms, exposure history, and confirmatory laboratory testing.

Negative

A negative result means the target marker was not detected at the test’s detectable level. If Zika infection is still suspected, further testing may be required.

Invalid

If the control line does not appear, the result is invalid and testing should be repeated with a new device.

Instructions

• Store as per product label instructions
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Use before expiry date
• Use proper sample handling precautions
• Follow the instructions for use carefully
• Use immediately after opening the pouch

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides rapid diagnostic products designed for global healthcare markets. The Zika Rapid Test Device supports professional infectious disease screening with simple handling, rapid results, and practical diagnostic workflow.

Advantages

• International infectious disease rapid test portfolio
• Export-ready diagnostic product range
• Suitable for hospitals, clinics, and laboratories
• Professional healthcare quality focus
• Practical point-of-care testing format
• Reliable supply support for distributors
• Designed for global diagnostic requirements